On December 9, 2019, HPGC Renmintongtai Pharmaceutical Corporation (SHSE:600829) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.71 CNY | +4.96% | -1.21% | -26.98% |
1st Jan change | Capi. | |
---|---|---|
-26.98% | 434M | |
+29.50% | 78.4B | |
+0.30% | 25.12B | |
+14.70% | 8.62B | |
+2.20% | 8.55B | |
-28.87% | 6.91B | |
+16.06% | 5.34B | |
+1.58% | 4.17B | |
-8.90% | 3.82B | |
-7.62% | 3.37B |
- Stock Market
- Equities
- 600829 Stock
- News HPGC Renmintongtai Pharmaceutical Corporation
- HPGC Renmintongtai Pharmaceutical Corporation announced that it has received funding from Harbin Pharmaceutical Group Co., Ltd.